%PDF-1.4
%
49 0 obj
<>
endobj
46 0 obj
<>
endobj
197 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-08-09T10:28:21Z
2024-03-28T05:59:51-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T05:59:51-07:00
application/pdf
Heather
2004-170.sept
uuid:1609e909-1dd2-11b2-0a00-2d09277d8900
uuid:1609e90b-1dd2-11b2-0a00-d30000000000
endstream
endobj
35 0 obj
<>
endobj
36 0 obj
<>
endobj
50 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 23 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 25 0 R/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 27 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 29 0 R/Type/Page>>
endobj
214 0 obj
[219 0 R]
endobj
215 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6234 0.7818 -0.7818 0.6234 10.4844 52.3976 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
12 789 587 -785 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.084 Tw 9.7 0 0 10 54.5 734.3264 Tm
(important goal in early arthritis than it is in established RA.)Tj
0.06059 Tw 0 -1.2 TD
(As our knowledge expands, as innovative imaging technolo-)Tj
-0.011 Tw T*
[(gy becomes better)40 (, more standardized and less expensive, and)]TJ
0.02299 Tw T*
(as biomarkers and predictors improve, a greater clarity of the)Tj
0.05029 Tw T*
(presence and extent of the window of opportunity will allow)Tj
0.02499 Tw T*
[(more refined treatment options. For now)65 (, \322do no harm.\323)]TJ
/T1_2 1 Tf
-0.0298 Tw 13.1959 -2.4 Td
[(STEPHEN A. )-55 (P)74 (AGET)74 (,)]TJ
/T1_1 1 Tf
0 Tw 5.82 0 0 6 279.0744 650.3264 Tm
(MD,)Tj
0.02499 Tw 7.76 0 0 8 182.5 640.3264 Tm
(Physician-in-Chief and Chairman, )Tj
0 -1.25 TD
[(Division of Rheumatology)65 (, )]TJ
T*
[(Hospital for Special Sur)18 (gery)65 (,)]TJ
T*
(535 East 70th Street,)Tj
0 Tc -0.0119 Tw T*
[(New Y)100 (ork, )-37 (New Y)100 (ork )-37 (10021, )-37 (USA.)]TJ
/T1_3 1 Tf
-0.00011 Tc 0.02499 Tw -16.4948 -2.5 Td
[(Addr)37 (ess r)37 (eprint r)37 (equests to Dr)111 (. Paget.)]TJ
/T1_1 1 Tf
15.4808 0 Td
(E-mail: pagets@hss.edu)Tj
/T1_2 1 Tf
0 Tw 9.7 0 0 10 54.5 556.3264 Tm
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 61.5 546.3264 Tm
[(1.)-875 (Pincus )18 (T)74 (, Smolen JS, editors. Early arthritis. Clin Exp Rheumatol)]TJ
0 Tc 1.675 -1.25 Td
(2003;21 Suppl 31:S1-S210.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(2.)-875 (W)80 (olfe F)80 (, Ross K, Hawley DJ, et al. )18 (The prognosis of rheumatoid)]TJ
1.675 -1.25 Td
[(arthritis and undif)18 (ferentiated polyarthritis syndrome in the clinic: a)]TJ
T*
[(study of 1)37 (141 patients. J Rheumatol 1993;20:2005-9.)]TJ
-1.675 -1.25 Td
[(3.)-875 (Zeidler H, Hulsemann JL. Benign polyarthritis and undif)18 (ferentiated)]TJ
1.675 -1.25 Td
[(arthritis. )55 (An epidemiologic terra incognita. Scand J Rheumatol)]TJ
0 Tc T*
(1989;Suppl 79:13-20.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(4.)-875 (T)35 (unn EJ, Bacon P)92 (A. Dif)18 (ferentiating persistent from self-limiting)]TJ
1.675 -1.25 Td
(symmetrical synovitis in an early arthritis clinic. Br J Rheumatol)Tj
0 Tc 0 Tw T*
(1993;32:97-103.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(5.)-875 (Symmons DPM, Hazes JMW)92 (, Silman )55 (AJ. Cases of early)]TJ
1.675 -1.25 Td
(inflammatory polyarthritis should not be classified as having)Tj
T*
(rheumatoid arthritis. J Rheumatol 2003:30:902-4.)Tj
-1.675 -1.25 Td
[(6.)-875 (Quinn MA, Green MJ, Marzo-Ortega H. Prognostic factors in a)]TJ
1.675 -1.25 Td
[(lar)18 (ge cohort of patients with early undif)18 (ferentiated inflammatory)]TJ
T*
(arthritis after application of a structured management protocol.)Tj
T*
(Arthritis Rheum 2003;28:3039-45.)Tj
-1.675 -1.25 Td
[(7.)-875 (Schumacher HR. Early arthritis clinics. Much early arthritis is)]TJ
1.675 -1.25 Td
(unclassified. J Rheumatol 2002;29:2258-60.)Tj
31.2 47.421 Td
[(8.)-875 (Boers M. Understanding the window of opportunity concept in)]TJ
1.675 -1.25 Td
[(early rheumatoid arthritis. )55 (Arthritis Rheum 2003;48:1771-4.)]TJ
-1.675 -1.25 Td
[(9.)-875 (O\325Dell JR. )18 (T)35 (reating rheumatoid arthritis early: a window of)]TJ
1.675 -1.25 Td
[(opportunity? )55 (Arthritis Rheum 2002;46:283-5.)]TJ
-2.175 -1.25 Td
[(10.)-875 (Amjadi-Begvand S, Khanna D, Park GS, et al. Dating the \322window)]TJ
2.175 -1.25 Td
(of therapeutic opportunity\323 in early rheumatoid arthritis: accuracy)Tj
T*
(of patient recall of arthritis symptom onset. J Rheumatol)Tj
0 Tc 0 Tw T*
(2004;31:1686-920.)Tj
-0.00011 Tc 0.02499 Tw -2.1381 -1.25 Td
[(1)37 (1.)-875 (Jansen LMA, Schaardenbur)18 (g DV)129 (, Horst-Bruinsma IEVD, et al. )18 (The)]TJ
2.1381 -1.25 Td
(predictive value of anti-cyclic citrullinated peptide antibodies in)Tj
T*
(early arthritis. J Rheumatol 2003;30:1691-5.)Tj
-2.175 -1.25 Td
[(12.)-875 (Lee DM, Schur PH. Clinical utility of the anti-CCP)-238 (assay in)]TJ
2.175 -1.25 Td
[(patients with rheumatic diseases. )55 (Ann Rheum Dis 2003;62:870-74.)]TJ
-2.175 -1.25 Td
[(13.)-875 (Hitchon CA, el-Gabalawy HS. )18 (The histopathology of early)]TJ
2.175 -1.25 Td
(synovitis. Clin Exp Rheumatol 2003;21 Suppl 31:S28-S36.)Tj
-2.175 -1.25 Td
[(14.)-875 (McQueen FM, Benton N, Perry D, et al. Bone edema scored on)]TJ
2.175 -1.25 Td
(magnetic resonance imaging scans of the dominant carpus at)Tj
T*
(presentation predicts radiographic joint damage of the hands and)Tj
T*
[(feet six years later in patients with rheumatoid arthritis. )55 (Arthritis)]TJ
0 Tc T*
(Rheum 2003;48:1814-27.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(15.)-875 (Oster)18 (gaard M, Hansen M, Stoltenber)18 (g M, et al. New radiographic)]TJ
2.175 -1.25 Td
(bone erosions in the wrist of patients with rheumatoid arthritis are)Tj
T*
(detectable with magnetic resonance imaging a median of two years)Tj
T*
[(earlier)55 (. )55 (Arthritis Rheum 2003;48:2128-31.)]TJ
-2.175 -1.25 Td
[(16.)-875 (Quinn MA, Conaghan PG, Emery P)111 (. )18 (The therapeutic approach of)]TJ
2.175 -1.25 Td
(early intervention for rheumatoid arthritis: what is the evidence?)Tj
0 Tc T*
[(Rheumatology 2001;40:121)37 (1-20.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(17.)-875 (Roman MJ, Shanker BA, Davis )55 (A, et al. Prevalence and correlates)]TJ
2.175 -1.25 Td
(of accelerated atherosclerosis in systemic lupus erythematosus. )Tj
0 Tc T*
(N Eng J Med 2003;349:2399-406.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(18.)-875 (Lard LR, )18 (V)60 (isser H, Speyer I, et al. Early versus delayed treatment)]TJ
2.175 -1.25 Td
(in patients with recent-onset rheumatoid arthritis: comparison of)Tj
T*
[(two cohorts who received dif)18 (ferent treatment strategies. )55 (Am J Med)]TJ
0 Tc 0 Tw T*
[(2001;1)37 (1)37 (1:446-51.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(19.)-875 (van )55 (Aiken J, van Bilsen JHM, )55 (Allaart CF)80 (, et al. )18 (The Leiden Early)]TJ
2.175 -1.25 Td
(Arthritis Clinic. Clin Exp Rheumatol 2003;21 Suppl 31:S100-S105.)Tj
-2.175 -1.25 Td
[(20.)-875 (van der Heijde, Landewe R. Imaging: Do erosions heal? )55 (Ann)]TJ
2.175 -1.25 Td
(Rheum Dis 2003;62 Suppl 2:ii10.)Tj
ET
0 0 0 1 K
53.46 77 m
558.47 77 l
S
0 0 0 0 k
52.32 70.16 64.18 -15.66 re
f*
BT
0 0 0 1 k
/T1_3 1 Tf
0 Tc 0 Tw 8 0 0 8 53.3216 57.2343 Tm
(1676)Tj
ET
0 0 0 0 k
355.5 70.16 203 -15.66 re
f*
BT
0 0 0 1 k
/T1_3 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 423.8613 57.2343 Tm
(The Journal of Rheumatology 2004; 31:9)Tj
ET
0 0 0 0 k
/GS0 gs
102.25 82.08 407.5 -10.83 re
f*
0.5 w
102.25 82.08 407.5 -10.83 re
S
Q
Q
q
1 0 0 1 0 5 cm
0 0 612 792 re
W n
1 0 0 1 0 -5 cm
BT
0 0 0 rg
ET
/GS2 gs
BT
/T1_4 8 Tf
110.368 74 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
29 0 obj
<>stream
8;Z\7m>cfQ%*SO_?s`#<:cg:oIZ<0E;_4`L/P;S`EPXg.O'l7`&P&(PbE(u`+59uF
REfc4Q.C2n>GDosW7-$/\njo2DMt#,^,$
k^+Iagd[=S7#a+8mN*L(C(hL_-Q@eEOcuRQZK9ZH4o1laR/OH0Jut"+UOV[5Ysg.@
`Tbr7M!EZQksYneo0`61J^%;S^f@l2jpQ*iNB1^"<$'Us3@6$&h"9M::moo,,VPSB
[RSb^\iV%R_c(gHaJ!+L$R!t`]m$_-tr(a[%r]$/#K3hFiCd&Vsp@]]2fX*W(H
7S)/;c^%/SF!BH^
endstream
endobj
33 0 obj
[/Indexed/DeviceRGB 255 32 0 R]
endobj
32 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
84 0 obj
<>
endobj
52 0 obj
<>
endobj
16 0 obj
<>
endobj
56 0 obj
<>
endobj
75 0 obj
<>
endobj
203 0 obj
<>
endobj
55 0 obj
<>
endobj
63 0 obj
<>stream
H TSW# jѡnS[" EA6K)K!@5vʀŽ)jAeqzZ3eL99㘹BW]v>"Pj.?dxc3[d`0̎ú1gEhM6/(x9l贀u6V_XaS
MvIbH`]دm}w2 %B\*0I|$>D&wRAP*O4Yg" D CQD&
]!1$O*BEBϾo][n,a+0lfa17f؇B``kS1F`˱l__]5b41" ҃fc,MyQsL͕=Ǟ#o7cK"bxm\dNXhIcBssccssBD fK
!\ea
]ZViWsinN*몹pv10:G=AjOoߺIE5TYDy'$.T^x]$-SXR:}$$RE5Ut:#/9|OtРSc|n#?LV
<M}yȒ5b!(TJ| )TG5eUڡ'
|#:X(a 4J aܴ>,&@rr%JۀġK{<]wŪj&Q2KSRr&M%N@MbH"4p}hd5CQɶ[_+|}kzBӛ
䦶MAT#%E;y'#G(EK=!Eʨ8̍oJǙpg
=:h9?%ib%qdynvѦn(8(oYƅt8!H\q!n_e]=TOݽ^*TxYzw[uo)rtuƖ^=!eSeYuKu?xhy'=cm뎸Ru|2P=̪ߖ[~q^}9i lе{~7v'T
U~hZal(H6.N\.99&$QjS.覸)LS)dk
p6RSWu^_ߩץG(YVY4I"MIKUQyi:9L[/#0u8ci`1VF'zo*UhocHmZSJ@Gk_8״cI*=_ü"
ȏ2x)0XrvK_N` 7ylg\aط]/L1+0oZs.ͺ\6oN_~3|4NM5K/Ӡ;-Y)}Hֺׂ+y%@Hyh>y'4yռW7
i1i]6V&=;DzwwԈR/':>Be`5Q,B,Rajơ"ɷJcikܯVє\EuOr~VOgFDd%jt5fԟJ5(ΛzyVvxy}w$8Nch%o(X4Хue%ڢΒ+%-1mQ4j{`Ե?{n/a̅1ktdJpUC6_ g&-'ǖ յ)Z>_b{鈮ImF,zbLm.'5eR(]e[?/43 g&0֩Rj[ov`[@C$\[ @n*E[:]7*h[;~؝=[7|yy߬hxF%FJK%r/
JX$S}=;WQ3rl,6b&c?Y#Ȥe$@GکcTJ{GG!`5ҵk8buŘN@,[˰MŤҩM8ұzQm#ߕ
0ce}T >VׇBe`CAϗkBEby$$h9\N
2fx_qPq~I4+R"ul~Qj^IY[N:)' Q*A$L3o"N0v,Hp8 wT;*&݇: